- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05670236
Effect of Knee Pain on Walking Biomechanics
The goal of this study is to determine if pain in one knee influences loading of the other knee during different types of walking. The main questions it aims to answer are:
- How does unilateral knee pain affect contralateral knee joint loading during different types of walking?
- Does movement and loading change at the hips, knees, and ankles during prolonged walking in persons with painful knee osteoarthritis?
Participants will:
- Fill out questionnaires/surveys
- Complete clinical examinations
- Walking on a treadmill under different types of walking conditions
- Receive two knee injections For comparison purposes, researchers will also enroll healthy participants.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study will evaluate the effects of unilateral knee pain on contralateral knee joint loading during different types of walking. Thirty adults with unilateral symptomatic knee osteoarthritis will complete four, 1.5-hour study visits. The first and third visits will include level, inclined, and declined walking at comfortable, fast, and slow speeds. The second and fourth visits will include a 30-minute walk. There will be at least two days between visits. The only difference between each pair of visits is that one visit will involve walking with unilateral knee pain (painful walking) and the other visit will involve walking without unilateral knee pain (nonpainful walking). Individuals will be recruited based on the presence of unilateral knee pain so the painful walking will be representative of their typical walking. For the visits with nonpainful walking, the third and fourth visits, pain will be alleviated by performing an intraarticular injection with a local anesthetic (lidocaine hydrochloride). All walking will be performed in a three-dimensional motion capture environment on a split-belt treadmill that is instrumented with force plates.
A cohort of 30 healthy individuals will complete the same walking conditions at two, 1.5-hour study visits. The healthy control group will not receive intraarticular knee injections. The purpose of this cohort is to better understand how walking mechanics in individuals with unilateral knee osteoarthritis compare to similar individuals without knee osteoarthritis.
Study Type
Enrollment (Estimated)
Phase
- Phase 4
Contacts and Locations
Study Contact
- Name: Patrick Corrigan, DPT, PhD
- Phone Number: 314-977-8541
- Email: patrick.corrigan@health.slu.edu
Study Locations
-
-
Missouri
-
Saint Louis, Missouri, United States, 63104
- Recruiting
- Saint Louis University
-
Contact:
- Patrick Corrigan, DPT, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria for Knee Osteoarthritis Arm:
- At least 45 years old
- Unilateral knee pain with walking that averages at least 3 out of 10 on a numeric pain rating scale
- Unilateral knee stiffness that lasts less than 30 minutes after periods of inactivity
- Unilateral symptoms on most days for at least the past 3 months
Exclusion Criteria for Knee Osteoarthritis Arm:
- History of knee replacement surgery
- Opiate use within the past 3 months
- Narcotic use within the past 3 months
- Known medical condition that affects walking mechanics, besides knee osteoarthritis
- Known medical condition that affects pain perception
- Inability to walk for 30 minutes without using an assistive device
- Body weight greater than 300 pounds
- Known allergy to adhesives
- High risk for a cardiovascular event
- Currently pregnant
- Anticoagulant use within the past 3 months
- Intraarticular knee injection within the past 3 months
- Known history of hypersensitivity to local anesthetics of the amide type
- History of lower body pain or injury, besides knee osteoarthritis, within the past 6 months
Inclusion Criteria for Healthy Arm:
- At least 45 years old
- No lower body pain or injury within the past 6 months
Exclusion Criteria for Healthy Arm:
- History of knee replacement surgery
- Opiate use within the past 3 months
- Narcotic use within the past 3 months
- Known medical condition that affects walking mechanics
- Known medical condition that affects pain perception
- Inability to walk for 30 minutes without using an assistive device
- Body weight greater than 300 pounds
- Known allergy to adhesives
- High risk for a cardiovascular event
- Currently pregnant
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Knee Osteoarthritis
Individuals with clinically defined unilateral symptomatic knee osteoarthritis.
|
10 mL of 1% lidocaine hydrochloride for each intraarticular knee injection
|
No Intervention: Healthy
Individuals who serve as healthy controls.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in medial knee contact forces during walking
Time Frame: Change from baseline to immediately after treatment
|
Contact forces estimated with musculoskeletal modeling
|
Change from baseline to immediately after treatment
|
Change in lateral knee contact forces during walking
Time Frame: Change from baseline to immediately after treatment
|
Contact forces estimated with musculoskeletal modeling
|
Change from baseline to immediately after treatment
|
Change in patellofemoral knee contact forces during walking
Time Frame: Change from baseline to immediately after treatment
|
Contact forces estimated with musculoskeletal modeling
|
Change from baseline to immediately after treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in knee joint angles during walking
Time Frame: Change from baseline to immediately after treatment
|
Angles derived from kinematic analyses
|
Change from baseline to immediately after treatment
|
Change in knee joint moments during walking
Time Frame: Change from baseline to immediately after treatment
|
Moments derived from kinetic analyses
|
Change from baseline to immediately after treatment
|
Change in knee joint work during walking
Time Frame: Change from baseline to immediately after treatment
|
Work derived from energetic analyses
|
Change from baseline to immediately after treatment
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Patrick Corrigan, DPT, PhD, St. Louis University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Joint Diseases
- Musculoskeletal Diseases
- Rheumatic Diseases
- Arthritis
- Osteoarthritis
- Osteoarthritis, Knee
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Anti-Arrhythmia Agents
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Sensory System Agents
- Anesthetics
- Membrane Transport Modulators
- Anesthetics, Local
- Voltage-Gated Sodium Channel Blockers
- Sodium Channel Blockers
- Lidocaine
Other Study ID Numbers
- 32283
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoarthritis, Knee
-
LifeBridge HealthMicroPort Orthopedics Inc.; Rubin Institute for Advanced OrthopedicsRecruitingKnee Osteoarthritis | Osteoarthritis, Knee | Knee Pain Chronic | Arthropathy of Knee Joint | Knee Disease | Osteoarthritis Knees Both | Osteoarthritis Knee Left | Osteoarthritis Knee RightUnited States
-
University Hospital, Clermont-FerrandSanofiCompletedKnee Osteoarthritis (Knee OA)France
-
Joseph E. BroylesCompletedDegenerative Lesion of Articular Cartilage of Knee | Degeneration; Articular Cartilage, Knee | Unilateral Primary Osteoarthritis of Knee | Osteoarthritis Knee
-
Jiangsu XinChen-Techfields Pharma Co., LTD.Completed
-
The Hong Kong Polytechnic UniversityCompleted
-
Federal University of São PauloCompletedKNEE OSTEOARTHRITISBrazil
-
Novartis PharmaceuticalsRecruitingSymptomatic Knee OsteoarthritisUnited States, Spain, Hungary, Argentina, Germany, Slovakia, Czechia, Belgium, Romania
-
University of BathUniversity of Oxford; 3D Metal Printing Ltd; Versus ArthritisRecruitingMedial Knee OsteoarthritisUnited Kingdom
-
Max Biocare Pty. Ltd.Completed
Clinical Trials on Lidocaine Hydrochloride
-
Rajmonda Nallbani-KomoniUnknownAnalgesic Drug DependenceKosovo
-
Lahey ClinicWithdrawn
-
Gil YosipovitchTerminated
-
Hospital de BaseCompleted
-
Tianjin Medical University General HospitalCompleted
-
Zeng ChanghaoRecruiting
-
Carilion ClinicWithdrawn
-
The Catholic University of KoreaWithdrawnthe Effect of Dexmedetomidine and Licodaine on Acute Postoperative Pain in Gynecological LaparoscopyGynecologic DiseaseKorea, Republic of
-
University Health Network, TorontoCompletedUterine LeiomyomasCanada
-
Jinling Hospital, ChinaCompleted